Copyright
©The Author(s) 2025.
World J Hepatol. Mar 27, 2025; 17(3): 104715
Published online Mar 27, 2025. doi: 10.4254/wjh.v17.i3.104715
Published online Mar 27, 2025. doi: 10.4254/wjh.v17.i3.104715
Figure 2 Inhibitor action in the cell.
Inhibitors reduce the uptake of glucose by tumour cells, reduce the ability of tumour cells to add value and induce apoptosis by competing with glucose transporter proteins (GLUTs) for glucose-binding targets and inhibiting the function of GLUTs. GLUT: Glucose transporter proteins.
- Citation: Ruan Z, Wang Y, Shi L, Yang XJ. Progress of research on glucose transporter proteins in hepatocellular carcinoma. World J Hepatol 2025; 17(3): 104715
- URL: https://www.wjgnet.com/1948-5182/full/v17/i3/104715.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i3.104715